Dr. Okam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Brigham And Womens Hospital Hematology Division
Boston, MA 02115Phone+1 617-732-5048Fax+1 617-732-5706
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
St Luke's University Hospital/Easton HospitalResidency, Internal Medicine, 1998 - 2001
University of Port Harcourt College of Health ServicesClass of 1995
Certifications & Licensure
MA State Medical License 2005 - 2026
FL State Medical License 2020 - 2022
CT State Medical License 2003 - 2006- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Start of enrollment: 2005 Aug 01
- Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease Start of enrollment: 2009 Oct 01
- A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Publications & Presentations
PubMed
- 41 citationsComparative rates of adverse events with different formulations of intravenous iron.Maureen Okam, Elyse Mandell, Nathanael D. Hevelone, Rachel Wentz, Ainsley Ross
American Journal of Hematology. 2012-11-01 - 337 citationsThe risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-upMartin H. Steinberg, William F. McCarthy, Oswaldo Castro, Samir K. Ballas, F. Danny Armstrong
American Journal of Hematology. 2010-06-01 - 39 citationsRefining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (PROACTIVE)Lori Styles, Carrie G. Wager, Richard J. Labotka, Kim Smith-Whitley, Alexis A. Thompson
British Journal of Haematology. 2012-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
